GENERAL COMMENTS
The manuscript #bmjopen-2019-029823 reports a retrospective analysis of the US National Inpatient Sample aimed at verify he influence of obesity on the outcomes of curative liver resection.
1) Introduction, please focus on literature and results deriving from liver surgery only. Obesity and other kind of surgical procedures are introducing other clinical aspects which would not fully fit the aim of the present study.
2) Despite the US database, all Authors are from Gaungdong, China. Thus, somewhere in the text it should be described how Authors obtained these data. Probably through request to the Online HCUP Central Distributor.
3) Methods are clearly described but lacks of some details on how hospital costs were counted.
4) In the Results section, "income by ZIP code" should be explained (i.e. in the footnotes of Table 1 ). Please change "hepatic preconditions" with some different and more specific definition. In addition, since the data on steatosis, fibrosis and cirrhosis lacked for more than 80% of data, I was wondering the need to retain this variable in the analysis. Probably, results will benefit from its exclusion.
5) The study is interesting but lacks obviously on data ragarding tumor stage and, consequently, hepatectomy extension. It is likely that extension of hepatectomy would be different in obese and non-obese patients. The simple division between lobectomy and partial hepatectomy do not account for the extension of the liver resection. Please somewhere discuss this aspect. The manuscript #bmjopen-2019-029823 reports a retrospective analysis of the US National Inpatient Sample aimed at verify he influence of obesity on the outcomes of curative liver resection.
6) In the
Reply: Thank you for your suggestions. We have deleted the statement of obesity and other surgeries in the Introduction section. In addition, we have expanded the information regarding obesity and liver surgery, and added the references [10, [13] [14] [15] [16] .
Reply: Yes, we obtained the data through request to the Online Healthcare Cost and Utilization Project (HCUP) Central Distributor. (https://www.distributor.hcup-us.ahrq.gov/) This information has been added to the Methods section.
Reply: As suggested, we have added details of how hospital costs were counted in the paragraph of primary endpoints, in the Methods section.
4) In the Results section, ribbed but lacks of s should be explained (i.e. in the footnotes of Table 1 ). Please change costs were" with some different and more specific definition. In addition, since the data on steatosis, fibrosis and cirrhosis lacked for more than 80% of data, I was wondering the need to retain this variable in the analysis. Probably, results will benefit from its exclusion.
Reply: As suggested, we have added an explanation of "income by ZIP code" in the footnote of Table  1 . We kept the data on steatosis, fibrosis, and cirrhosis, but changed the term 'hepatic preconditions' to 'Liver cirrhosis/steatosis/fibrosis' to be more specific, as suggested.
5) The study is interesting but lacks obviously on data regarding tumor stage and, consequently, hepatectomy extension. It is likely that extension of hepatectomy would be different in obese and nonobese patients. The simple division between lobectomy and partial hepatectomy do not account for the extension of the liver resection. Please somewhere discuss this aspect.
Reply: Thank you for your comment. This is indeed a limitation of database analyses, such as this study. We have added the information below to the discussion of the limitations of the study.
Data of tumor stage were included in the analysis, and the extension of hepatectomy (if any) was unknown due to lack of this information in the database. The simple division between lobectomy and partial hepatectomy in the analyses might not account for extension of the liver resection, and thus may potentially bias the results. This is indeed another limitation of database analyses. Clinical studies are necessary to determine the importance of extension of hepatectomy in obese and nonobese patients. Table 4 is not clear what is the reference for the reported beta-coefficients (please report as in the text of the Results section)
Reply: Table 4 shows the impact of obesity on each of the endpoints in the different subgroups (stratifications). The reference group is non-obese patients in these analyses.
For example, aOR = 1.33 (1.04-1.69) means among patients who received a lobectomy, obese patients are more likely to experience postoperative complication than non-obese patients, after adjustment.
As for the β coefficient, we have added 'Unadjusted' and 'Adjusted' for clarity. The 'Adjusted' β indicates the association of obesity and length of stay in multivariate analyses in each subgroup. The results clearly show that obesity was not associated with length of stay in any subgroup. (Table 4) We have already reported this information in the text.
7) In the Results section it was stated that ication than non-obeseed beta-coefficients (please report as in the text of the Results section)e discushen, after multi-variable, that "No significant difference was observed in length of stay". Please highlight the change of this result in this section.
Reply: The description in the Result section has been revised accordingly to highlight this change.
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